A new cholesterol lowering drug called Praluent was recently approved by the U.S. Food and Drug Administration and introduced to…
Read More
Patients seeking alternatives to statins may undergo rigorous vetting
A powerful new class of drugs promises to change the management of heart disease for high-risk patients who struggle to…
Read More
New recommendations for overweight people with heart risks
NEW YORK – Overweight patients with risk factors for heart disease should be sent by their doctors for “intensive behavioral…
Read More
